Cargando…
Development of a preclinical humanized mouse model to evaluate acute toxicity of an influenza vaccine
Safety evaluation of a human vaccine is critical for vaccine development and for preventing an unexpected adverse reaction in humans. Nonetheless, to date, very few systems have been described for preclinical studies of human adverse reactions in vivo. Previously, we have identified biomarker genes...
Autores principales: | Sasaki, Eita, Momose, Haruka, Hiradate, Yuki, Furuhata, Keiko, Mizukami, Takuo, Hamaguchi, Isao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995229/ https://www.ncbi.nlm.nih.gov/pubmed/29899819 http://dx.doi.org/10.18632/oncotarget.25399 |
Ejemplares similares
-
Immunogenicity and Toxicity of Different Adjuvants Can Be Characterized by Profiling Lung Biomarker Genes After Nasal Immunization
por: Sasaki, Eita, et al.
Publicado: (2020) -
Modeling for influenza vaccines and adjuvants profile for safety prediction system using gene expression profiling and statistical tools
por: Sasaki, Eita, et al.
Publicado: (2018) -
Changes of urine metabolite profiles are induced by inactivated influenza vaccine inoculations in mice
por: Sasaki, Eita, et al.
Publicado: (2019) -
Nasal alum-adjuvanted vaccine promotes IL-33 release from alveolar epithelial cells that elicits IgA production via type 2 immune responses
por: Sasaki, Eita, et al.
Publicado: (2021) -
Impact of the SCF signaling pathway on leukemia stem cell-mediated ATL initiation and progression in an HBZ transgenic mouse model
por: Kuribayashi, Wakako, et al.
Publicado: (2016)